Despite its controversial reputation and association with negative imagery in popular culture, electroconvulsive therapy (ECT) proved life-saving for an author who suffered from treatment-resistant depression. After attempting various conventional treatments without success, the individual opted for ECT in 2021, a procedure involving electrical currents to induce brief seizures while under anesthesia.
The patient described the treatment regimen as intensive, receiving around two dozen sessions—roughly twice the typical course of 10 to 12 treatments recommended by current standards. While the procedure resulted in some memory loss, the author noted that cognitive function eventually improved, allowing them to resume writing and performing music. The author states that five years after the last session, they have lived a significantly happier life, including getting married and publishing a new book.
Harold Sackeim, a professor of psychiatry at the Medical University of South Carolina, explains that modern psychiatry often reserves ECT as a last resort for patients who have exhausted options such as talk therapy and multiple types of antidepressants, including SSRIs, tricyclics, and MAOIs. Sackeim notes that this approach effectively limits ECT to the most resistant cases, meaning patients may wait years for a treatment that could have been effective earlier.
Emerging research supports the author’s perspective, indicating that ECT can stimulate neurogenesis—the production of new neurons—and promote growth in the hippocampus, a brain region that often shrinks during sustained depression. Consequently, delaying ECT may lead to more severe long-term cognitive impairment compared to earlier intervention.
While acknowledging that ECT has side effects and is not suitable for everyone, the author advocates for a shift in how the treatment is prescribed to prevent patients from enduring prolonged periods of unlivable depression. For those in crisis, resources are available through the 988 Suicide and Crisis Lifeline.
The memory loss aspect worries me, but knowing it stimulates new neuron growth makes me less skeptical.
It is wild that ECT is still viewed as a last resort instead of a viable option for many.